Alopecia Market Size, Share, Growth, Sales Revenue and Key Drivers Analysis Research Report by 2028

Market Trends – Increasing number of initiatives to raise awareness about alopecia among people

NEW YORK, NY, UNITED STATES, April 15, 2022 /EINPresswire.com/ — The global alopecia market size is expected to reach USD 13.80 Billion in 2028 at a CAGR of 5.1% during the forecast period, according to the latest report by Reports and Data. Increasing prevalence of hair loss caused due to chronic diseases, rising caseload of persistent chemotherapy-induced alopecia, advancements in alopecia diagnosis and treatment, and growing number of clinical trials across the globe to develop effective treatments for alopecia are key factors expected to drive market revenue growth over the forecast period. In addition, increasing number of initiatives by government of various countries across the globe to raise awareness about the condition and to accelerate alopecia research is another key factor expected to support market revenue growth going ahead.

Alopecia is referred to as hair loss that can occur anywhere on the body. Alopecia can be divided into two main categories: scarring and non-scarring. The most common type of alopecia is androgenetic alopecia, which is a disorder that affects nearly 50% of men and 15% of women, particularly postmenopausal women. Other types of alopecia include alopecia areata, telogen effluvium, cicatricial alopecia, and traumatic alopecia, among others. Alopecia is usually divided into disorders where the hair follicle is normal but there is abnormality in hair cycle and disorders where the hair follicle is damaged. Alopecia, in men and women, has been widely linked with significantly detrimental effects on body image, self-esteem, and psychological well-being. Growing prevalence of alopecia, primary and secondary, among individuals across the globe is leading to increasing demand for efficient treatment modalities that can provide satisfying and long-term results. This is further leading to development of well-designed clinical trials to evaluate safety and efficacy of newly identified molecules and compounds in treatment of alopecia and is a key factor expected to fuel revenue growth of the global market over the forecast period.

Get a sample of the report @ 

Commonly available therapeutic options for alopecia includes mesotherapy, microneedling, platelet-rich plasma, low-level laser therapy, and adipose-derived fat stem cell therapy. Increasing affordability of these therapies, growing popularity of off-label and over-the-counter medications, and rising consumption of dietary supplements to prevent and control hair loss are some other key factors expected to drive market revenue growth. However, high costs of treatments, lack of awareness among individuals in developing and underdeveloped countries, and lack of favorable reimbursement policies are some key factors that could restrain market revenue growth to a certain extent.

Some Key Highlights from the Report:

Alopecia areata is expected to account for largest revenue share over the forecast period, attributable to rising global incidence of alopecia areata, increasing research & development activities to understand pathophysiology of alopecia areata, development of novel treatment approaches, and growing number of clinical trials to assess efficacy and response of novel therapies and drug candidates.

Pharmaceuticals segment is expected to register significantly fast revenue growth rate over the forecast period, owing to rising demand for prescription drugs to treat alopecia, increasing consumption of OTC drugs and off-label oral and topical medications, and increasing affordability of these medicines.

Male segment is expected to account for a significantly large revenue share over the forecast period, attributed to increasing incidence of alopecia and male pattern baldness, growing consumption of alcohol and tobacco, hormonal imbalance, and rising availability of various therapies for medical management of alopecia in men.

Prescriptions segment is expected to register steady revenue growth rate over the forecast period, attributable to rising preference of patients to visit dermatologists and trichologists for management of alopecia, increasing disposable income, growing demand for approved medications, and availability of wide range of prescription drugs.

North America is expected to dominate other markets in terms of revenue share over the forecast period, attributable to increasing prevalence of hair loss among men and women, rising incidence of chemotherapy-induced alopecia among cancer patients, availability of top-of-the-line treatment and surgical modalities, and presence of key players in countries in the region.

Major companies profiled in the market report include Cipla Inc., Johnson and Johnson AG, Transitions Hair Pty Ltd., Sun Pharmaceutical Industries Ltd., Merck & Co., Inc., Cirrus Hair Centers, Lexington International LLC, Vita-Cos-Med Klett-Loch GmbH, Follica, Inc., and Capillus.

To know more about the report @ 

Alopecia Market Segmentation:

Disease Type Outlook (Revenue, USD Billion; 2018-2028)

Alopecia Areata
Cicatricial Alopecia
Traction Alopecia
Alopecia Totalis
Androgenetic Alopecia
Others

Treatment Outlook (Revenue, USD Billion; 2018-2028)

Pharmaceuticals
Devices

Gender Outlook (Revenue, USD Billion; 2018-2028)

Male
Female

Distribution Channel Outlook (Revenue, USD Billion; 2018-2028)

Prescriptions
Over-the-Counter

Global Alopecia Market Report: Regional Segmentation

North America
U.S.
Canada
Mexico
Europe
Germany
U.K.
Italy
France
BENELUX
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
Middle East & Africa
Saudi Arabia
A.E.
South Africa
Rest of MEA

Download Summary @ 

Global Alopecia Market: Table of Contents

Chapter 1. Methodology & Sources

1.1. Market Definition

1.2. Research Scope

1.3. Methodology

1.4. Research Sources

       1.4.1. Primary Sources

       1.4.2. Secondary Sources

       1.4.3. Paid Sources

1.5. Market Estimation Technique

Chapter 2. Executive Summary

Chapter 3. Key Insights

Chapter 4. Global Pharma & Healthcare Market Segmentation 

4.1. Global Pharma & Healthcare Market COVID-19 Impact Analysis

4.2. Industrial Outlook

       4.2.1. Market indicators analysis

       4.2.2. Market drivers’ analysis

       4.2.3. Market restraints analysis

 4.3. Technological Insights

 4.4. Porter’s Five Forces Analysis

 4.5. Regulatory Framework

 4.6. Price trend Analysis

 4.7. Competitive Metric Space Analysis

Request a customization of the report @ 

Frequently Asked Questions Answered in the Report:

What is the estimated revenue growth rate of the global Alopecia market over the forecast period?
What are the major factors driving the global market revenue growth?
Which are the leading manufacturers and suppliers in the global Alopecia market?
Which regional market is expected to lead in terms of revenue share in the global Alopecia market over the forecast years?
What are the key outcomes of SWOT analysis and Porter’s Five Forces analysis of the market?

Thank you for reading our report. Please connect with us to know more about the report and its customization feature. Our team will ensure the report is well suited to meet your requirements.

Browse More Reports:

High Potency Active Pharmaceutical Ingredients (HPAPI) Market @

Electronic Clinical Outcome Assessment (eCOA) Solution Market @

Dental Lasers Market @

Oligonucleotide Synthesis Market @

Robotic Rehabilitation and Assistive Technologies Market @

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Tushar Rajput
Reports and Data
+18008193052 ext.
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn